Pauline Jen Ryan
Corporate Officer/Principal bij OCULAR THERAPEUTIX, INC.
Oorsprong van het eerstegraads netwerk van Pauline Jen Ryan
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
| Subsidiary | Biotechnology | 12 | |
| Extinct | Biotechnology | 3 | |
Red Sky Partners LLC
2
| Private Company | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Pauline Jen Ryan via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
American Academy of Ophthalmology, Inc.
 American Academy of Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
IanTech, Inc.
 IanTech, Inc. Medical SpecialtiesHealth Technology IanTech, Inc. develops ophthalmic devices for cataract surgery. Its products include miLoop, miPhaco, miMissions, and miResources. The company was founded by Luke Clauson and Sean Ianchulev and is headquartered in Reno, NV. | Medical Specialties | Director/Board Member Director/Board Member | |
| American Society of Retinal Specialists | Director/Board Member Director/Board Member | ||
| The American Society of Cataract & Refractive Surgery | Director/Board Member President | ||
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Encore Vision, Inc.
 Encore Vision, Inc. Medical/Nursing ServicesHealth Services Encore Vision, Inc. operates as an ophthalmology clinic. It offers EV06, an ophthalmic pharmaceutical solution in a conventional eye drop bottle, which includes its proprietary active pharmaceutical ingredient (API). The company is headquartered in Spokane, WA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Chairman President | |
TherOptix, Inc.
 TherOptix, Inc. Electronic ComponentsElectronic Technology TherOptix, Inc. develops and manufactures drug-eluting contact lens. The company is headquartered in San Francisco, CA. | Electronic Components | Director/Board Member Director/Board Member | |
| American Society of Cataract & Refractive Surgery Foundation | Director/Board Member Chairman | ||
| HARROW, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
| Macula Society | Corporate Officer/Principal Corporate Officer/Principal | ||
| The Retina Society | Corporate Officer/Principal Director/Board Member | ||
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Formation Biologics Corp.
 Formation Biologics Corp. Miscellaneous Commercial ServicesCommercial Services Formation Biologics Corp. operates as a biopharmaceutical drug development company. It discovers and develops drugs and medicines for treatment of patients with cancers and orphan diseases. The company was founded in 2011 and is headquartered in Austin, TX. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
35Pharma, Inc.
 35Pharma, Inc. Pharmaceuticals: MajorHealth Technology 35Pharma, Inc. designs and develops biologics for diseases of high unmet medical need. The CEO of the Canadian company is Ilia A. Tikhomirov. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
Anchor Therapeutics, Inc.
 Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Middlebury College | College/University | Undergraduate Degree Undergraduate Degree | |
Surface Ophthalmics, Inc.
 Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Founder | |
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
WaveTec Vision Systems, Inc.
 WaveTec Vision Systems, Inc. Electronic ComponentsElectronic Technology WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA. | Electronic Components | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IDEXX LABORATORIES, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| TEARLAB CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
| Boston College | College/University | Undergraduate Degree Masters Business Admin | |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME. | College/University | Undergraduate Degree | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Founder | |
CDI Bioscience, Inc.
 CDI Bioscience, Inc. BiotechnologyHealth Technology CDI Bioscience, Inc. has developed an innovative technology for increased yield of bioproducts, manufactured in cellular systems. Genetic engineering technology is used to control the metabolism of cells, thus shifting the cell from explicative to production mode (RP Shift®). In particular, this technology has been designed for use in mammalian cells, unlocking their potential to produce proteins, peptides and enzymes. The current design of the technology can be readily translated to bacterial and yeast cellular systems for the production of commercial grade bio products. Recombinant therapeutic proteins have proven to be invaluable biopharmaceuticals for the treatment of chronic and life-threatening diseases. While exceptionally effective, the dosage requirements are generally very high for the required treatment. Several hundred milligrams of protein per administration is common and multiple doses are often required and being protein based drugs, they can only be produced by living cells which is why increasing production yield is a challenge. CDI Bioscience has developed a patented technology that dramatically improves the product yield in biopharmaceutical manufacturing. CDI's core technology, RP Shift®, solves a number of intermediate problems in the development of biopharmaceutical products by significantly boosting the productivity and viability of production cells. | Biotechnology | Director/Board Member | |
| American Society of Colon & Rectal Surgeons | Director/Board Member | ||
Aurion Biotech, Inc.
 Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | Medical/Nursing Services | Director/Board Member | |
Sydnexis, Inc.
 Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Sydnexis, Inc. engages in the production of ophthalmic pharmaceutical products. The company was founded by Gregory Isaac Ostrow in 2014 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| University of Iowa | College/University | Undergraduate Degree | |
INO Therapeutics LLC
 INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology INO Therapeutics LLC engages in the development of pharmaceutical drugs. The company is headquartered in Hampton, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
IOR Partners LLC
 IOR Partners LLC Medical SpecialtiesHealth Technology IOR Partners LLC develops office-based surgery suites. The company was founded by Rick Prell and is headquartered in Boulder City, NV. | Medical Specialties | Director/Board Member | |
Aquea Health, Inc.
 Aquea Health, Inc. Medical SpecialtiesHealth Technology Aquea Health, Inc. develops surgical solutions for treating glaucoma. The company is based in Burlingame, CA. The company was founded by Andy Doraiswamy and Charles M. Warden. The CEO is Charles M. Warden. | Medical Specialties | Chief Executive Officer | |
| The University of Chicago | College/University | Masters Business Admin | |
Inomax LLC (Florida)
 Inomax LLC (Florida) Investment ManagersFinance Inomax LLC is an American venture capital company. | Investment Managers | Corporate Officer/Principal | |
Datex-Ohmeda, Inc.
 Datex-Ohmeda, Inc. Industrial ConglomeratesProducer Manufacturing Part of General Electric Co., Datex-Ohmeda, Inc. develops and manufactures medical equipment. The company is based in Madison, WI. | Industrial Conglomerates | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 49 |
| Canada | 3 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Health Services | 3 |
| Electronic Technology | 3 |
Operationeel
| Director/Board Member | 202 |
| Corporate Officer/Principal | 85 |
| Independent Dir/Board Member | 48 |
| President | 36 |
| Undergraduate Degree | 31 |
Sterkste connecties
| Insiders | |
|---|---|
| Richard Lindstrom | 50 |
| Stephen Knight | 39 |
| Adrienne Graves | 38 |
| Charles Warden | 24 |
| Leslie Williams | 19 |
| Gregg Beloff | 18 |
| Mark B. Skaletsky | 18 |
| Pravin Dugel | 17 |
| Nicole Onetto | 17 |
| Stephen McCluski | 14 |
| Merilee Raines | 13 |
| Jeffrey S. Heier | 13 |
| John Tagliamonte | 12 |
| Alice Lin Pomponio | 11 |
| Daniel Junius | 10 |
- Beurs
- Insiders
- Pauline Jen Ryan
- Bedrijfsconnecties
